Cambridge Investment Research Advisors, Inc.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1419186
FAIRFIELD, IA
Position in BMRN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,249,055
+$954,347 QoQ
Shares Held
21,829
+318.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#251
of 561 holders
Holding Since
Jun 2020
21 quarters on record
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. BMRN ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in BMRN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,249,055 | 21,829 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $294,708 | 5,217 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $312,898 | 5,265 | Shares | Sole | 2026-02-05 | |
| 2024-09-30 | $246,717 | 3,510 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $252,753 | 3,070 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $222,367 | 2,546 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $274,893 | 2,851 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $248,540 | 2,809 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $352,094 | 4,062 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $494,854 | 5,089 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $635,221 | 6,138 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $481,324 | 5,678 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $661,302 | 7,980 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $650,261 | 8,434 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,027,068 | 11,625 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,660,189 | 21,480 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,515,771 | 18,166 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $724,744 | 9,598 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $477,384 | 5,444 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $316,264 | 4,157 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $521,851 | 4,231 | Shares | Sole | 2020-07-27 | |
| No filing history on record for this holder in this stock. | ||||||